Phenotypic Detection of Carbapenemase and AmpC‐β‐Lactamase Production among Extended Spectrum β‐Lactamase (ESBL)‐Producing Escherichia coli and Klebsiella spp., Isolated from Clinical Specimens
Zakaria Garba(Université Joseph Ki-Zerbo), Anu Kantele(Helsinki University Hospital), Nicolas Barro(Université Joseph Ki-Zerbo), Hamtandi Magloire Natama(Research Institute of Health Sciences), Isidore Juste O. Bonkoungou(Université Joseph Ki-Zerbo), Bérenger Kaboré(Institut de Recherche en Sciences de la Santé), Kaisa Haukka(University of Helsinki), Lassana Sangaré(Université Joseph Ki-Zerbo), Halidou Tinto(Institut de Recherche en Sciences de la Santé), ROUMBA Toussaint, Juha Kirveskari(University of Helsinki)
Cited by 4
Related Papers
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
|The Lancet|2021|457
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
|The Lancet|2024|345
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial
|The Lancet Infectious Diseases|2022|285
Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19
|Cell Reports Medicine|2020|209